-+ 0.00%
-+ 0.00%
-+ 0.00%

Gossamer Bio Q4 net loss rises 43.01% to USD 47.24 million on R&D expenses up 35.5% to USD 48.94 million

Reuters·03/17/2026 20:03:15

Please log in to view news